← Back to catalogue
Calcitonin ELISA [Enzyme-Linked ImmunoSorbent Assay]
FDA UDIClass II (US FDA UDI)
Identity
- Trade Name
- Calcitonin ELISA [Enzyme-Linked ImmunoSorbent Assay] FDA UDI
- Generic Name
- Calcitonin IVD, kit, enzyme immunoassay (EIA) FDA UDI
- Device Name
- The Biomerica Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum. This assay is intended for in vitro diagnostic use. FDA UDI
- Model / Reference
- 7024 FDA UDI
- Description
- The Biomerica Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum. This assay is intended for in vitro diagnostic use. FDA UDI
Identifiers
- Primary DI / UDI-DI
- 08305900070248 FDA UDI
- 510(k) Number
- K982491 FDA UDI
- FDA Product Code
- JKR FDA UDI
- GMDN Term
- Calcitonin IVD, kit, enzyme immunoassay (EIA) FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.1140 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Calcitonin ELISA [Enzyme-Linked ImmunoSorbent Assay] by Biomerica, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Cleared under the same submission
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biomerica, Inc.
Sources (1)
- FDA UDI 7aefee90-652d-48fe-b50e-3ae61b8ffd7d 36 fields · synced Jun 6, 2026